Clinical Trial to Assess Whether Cancer Therapy Tasigna Can Treat Parkinson’s
Georgetown University will conduct a clinical trial of Novartis’ cancer therapy Tasigna (nilotinib) as a treatment for Parkinson’s disease. The…
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Georgetown University will conduct a clinical trial of Novartis’ cancer therapy Tasigna (nilotinib) as a treatment for Parkinson’s disease. The…
Lowering the level of a certain protein can prevent PINK1 gene mutations from triggering an inherited type of Parkinson’s disease (PD), according…
Apomorphine infusion, delivered by a portable device, helps to treat Parkinson’s disease and allows reduced use of other medications that may cause…
An optimal Parkinson’s disease treatment would need to target both accelerator and brake functions in the brain to be effective…
Administering a naturally occurring growth factor to a mouse model of Parkinson’s disease reduced inflammation and prevented neurons from dying,…
Parkinson’s disease patients who are treated with deep brain stimulation may require fewer surgeries to replace the batteries in their stimulation…
A Phase 3 clinical trial (NCT01227655) in Parkinson’s disease patients on levodopa treatment showed that Bial’s Ongentys (opicapone)…
Researchers used brain stimulation to improve the time-assessment skills of mice whose dopamine  neurotransmitter had been removed, raising the possibility that…
Researchers have discovered that midbrain dopamine neurons — the neurons that die in patients with Parkinson’s disease — control how…
A point mutation in a gene involved in dopamine synthesis is linked to Parkinson’s disease characteristics but only in younger…
Get regular updates to your inbox.